Product Information

RELISTOR 12 MG/0.6 ML SYRINGE is a brand product labeled by Salix Pharmaceuticals Inc., priced at $272.6830 per ML under NDC 65649055103. Its NADAC has been published 588 times since Nov 28, 2013.

RELISTOR 12 MG/0.6 ML SYRINGE

Methylnaltrexone bromide
$272.6830per ML

Strength

12 mg/.6mL

NDC

65649055103

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

9/17/2025

Active Ingredients

METHYLNALTREXONE BROMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021964

On Market Since

4/24/2008

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Quaternary Ammonium Compounds

Price Statistics

The NADAC for RELISTOR 12 MG/0.6 ML SYRINGE has been published 588 times since Nov 28, 2013, and over the history we have for it it has risen 184.3%. The table below summarizes its recorded NADAC range and movement.

Current price$272.6830 per ML
All-time high$272.8943 (Sep 10, 2025)
All-time low$95.9067 (Nov 28, 2013)
52-week high$272.8943
52-week low$271.8619
Median price$199.4424
Average price$192.6783
Largest weekly change+38.8% (Sep 23, 2015)
Weeks tracked588
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.3%

3Y

+10.8%

5Y

+26.7%

All

+184.3%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 1%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of RELISTOR 12 MG/0.6 ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for RELISTOR 12 MG/0.6 ML SYRINGE, manufactured by Salix Pharmaceuticals Inc., is $272.6830 per ML (NDC 65649055103), effective Oct 1, 2025.

How has the price of RELISTOR 12 MG/0.6 ML SYRINGE changed over time?

Over the history we have for it, the NADAC for RELISTOR 12 MG/0.6 ML SYRINGE has risen 184.3%. It has been tracked across 588 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RELISTOR 12 MG/0.6 ML SYRINGE?

Since Nov 28, 2013, the NADAC for RELISTOR 12 MG/0.6 ML SYRINGE has ranged from a low of $95.9067 (Nov 28, 2013) to a high of $272.8943 (Sep 10, 2025), with a median of $199.4424 per ML.

Are there cheaper alternatives to RELISTOR 12 MG/0.6 ML SYRINGE?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, RELISTOR 12 MG/0.6 ML SYRINGE, is $271.2074 per ML — about 1% below RELISTOR 12 MG/0.6 ML SYRINGE.

Who manufactures RELISTOR 12 MG/0.6 ML SYRINGE?

RELISTOR 12 MG/0.6 ML SYRINGE (NDC 65649055103) is labeled by Salix Pharmaceuticals Inc., and CMS classifies it as a brand product.